4/30/2013

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended Genzyme's matrix-induced autologous chondrocyte implantation for marketing approval. The knee-repair product uses a porcine collagen scaffold seeded with autologous cartilage cells. The European Commission will make the final decision.

Related Summaries